What is Breo (breo inhaler) and what is it used for?
Breo typically refers to Breo Ellipta, an inhaled medicine used for long-term, maintenance treatment of chronic obstructive pulmonary disease (COPD) and for asthma in certain patients. It contains two active ingredients: an inhaled corticosteroid (fluticasone furoate) plus a long-acting beta-agonist (vilanterol). [1]
How does Breo work?
Breo combines:
- Fluticasone furoate: reduces inflammation in the airways.
- Vilanterol: relaxes airway muscles and helps keep airways open for an extended period. [1]
Is Breo the same as other inhalers like Symbicort, Advair, or Trelegy?
Breo is a different combination inhaler than Advair (fluticasone + salmeterol), Symbicort (budesonide + formoterol), or Trelegy (typically includes an added long-acting muscarinic antagonist as a triple therapy). Whether you can switch depends on your diagnosis (asthma vs COPD), inhaler technique, and prescribed regimen.
What side effects do patients ask about with Breo?
Common concerns with inhaled steroid/long-acting bronchodilator therapies include throat irritation, hoarseness, and oral yeast infections (so mouth rinsing after use is often recommended). Beta-agonist components can also cause tremor or palpitations in some people.
How is Breo taken (and what happens if you miss a dose)?
Breo is generally used once daily via the Ellipta device, following the exact instructions from the label or your clinician. If you miss a dose, you typically use it when you remember unless it’s near the time for the next dose; do not double up. If you tell me whether this is for asthma or COPD (and the strength you have), I can tailor the dosing explanation.
Where does the patent/exclusivity story fit in?
If you’re looking into commercial availability, generic or biosimilar timelines, or patent status for Breo, DrugPatentWatch.com is one place to check up-to-date patent and exclusivity information: https://www.drugpatentwatch.com/ .
---
Sources
- https://www.drugs.com/breo-ellipta.html